Purpose
It is Novozymes’s objective to have a stable, long-term focused, diversified base of institutional investors that share the company’s vision and strategy. Investor Relations supports this by:
- Creating long-term value through effective, insightful and open two-way communication the capital markets based on relevant, accurate, balanced and timely information as a basis for regular trading and fair pricing of Novozymes shares
- Maintaining an ongoing relationship with the capital markets to ensure Novozymes is perceived as a visible, accessible, reliable and professional company
- Conveying information from the capital markets back to Novozymes’ Executive Leadership Team and the Board of Directors
- Providing investors with insights into Novozymes at the Annual Shareholders Meeting
- Ensuring compliance with relevant rules and regulations
Investor Relations are responsible for planning, prepare and organize written and oral communication with the capital markets. In this respect, spokespersons are, unless otherwise agreed, the Executive Leadership Team and Investor Relations. Investor Relations is to be present at all interactions between company representatives and the capital markets. The primary interactions are roadshows, broker conferences, investor meetings and Capital Market Days. When asked to review analyst draft reports and financial models, Investor Relations will merely correct historical factual information, point out information that is publicly available in the public domain and discuss generally the factors that might influence the underlying assumptions used for future projections.